Evidence map›Paper›PMID 29588851›Full record

ArticleAntimicrobial resistance and infection control2018

Vancomycin-resistant

Andrew A Mahony, Andrew H Buultjens, Susan A Ballard, Elizabeth A Grabsch, Shirley Xie, Torsten Seemann, Rhonda L Stuart, Despina Kotsanas, Allen Cheng, Helen Heffernan and 8 more

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Vancomycin-resistant Enterococcus infections in a hospital in Salvador, Bahia: a descriptive study, 2021-2023.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Vancomycin Resistance inMicroorganisms · 2022
    Review
  8. Nosocomial outbreak of vancomycin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Outbreak of vancomycin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andrew A Mahony *1Department of Infectious Diseases, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084 Australia.
Andrew H Buultjens *3Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia.
Susan A Ballard1Department of Infectious Diseases, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084 Australia.
Elizabeth A Grabsch5Department of Microbiology, Austin Health, Heidelberg, VIC 3084 Australia.
Shirley Xie5Department of Microbiology, Austin Health, Heidelberg, VIC 3084 Australia.
Torsten Seemann6Melbourne Bioinformatics, The University of Melbourne, Parkville, VIC 3010 Australia.
Rhonda L Stuart7Monash Infectious Diseases, Monash Health, Clayton, VIC 3168 Australia.
Despina Kotsanas7Monash Infectious Diseases, Monash Health, Clayton, VIC 3168 Australia.
Allen Cheng8Department of Infectious Diseases, Alfred Health, School of Public Health and Preventive Medicine, Monash University, Prahran, VIC 3181 Australia.
Helen Heffernan9Antimicrobial Reference Laboratory, Institute of Environmental Science and Research (ESR), Wellington, 5022 New Zealand.
Sally A Roberts10Department of Clinical Microbiology, Auckland District Health Board, Auckland, 1051 New Zealand.
Geoffrey W Coombs11School of Veterinary and Life Sciences, Murdoch University, Murdoch, WA 6150 Australia.
Narin Bak13Department of Infectious Diseases, Royal Adelaide Hospital, Adelaide, South Australia 5000 Australia.
John K FergusonDivision of Microbiology, Health Pathology, NSW Department of Immunology and Infectious Diseases, John Hunter Hospital, University of Newcastle, Newcastle, NSW 2305 Australia.
Glen C Carter4Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia.
Benjamin P Howden3Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia.
Timothy P Stinear3Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000 Australia.
Paul D R Johnson1Department of Infectious Diseases, Austin Health, 145 Studley Rd, Heidelberg, VIC 3084 Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vancomycin-resistant Methods: Following near-simultaneous outbreaks of ST796 in multiple institutions, we gathered then tested colonization and bloodstream infection isolates' antimicrobial resistance (AMR) phenotypes, and phylogenomic relationships using whole genome sequencing (WGS). Patient meta-data was explored to trace the spread of ST796. Results: A novel clone of Conclusions: Evolution of new

Indexed as

Molecular EpidemiologyAustraliaBacterial ProteinsCross InfectionEnterococcus faeciumEpidemicsGram-Positive Bacterial InfectionsHospitalsHumansInfection ControlIntensive Care Units, NeonatalMicrobial Sensitivity TestsNew ZealandPhylogenyVancomycinVancomycin-Resistant EnterococciBacterial ProteinsVanB protein, EnterococcusVancomycinInfection controlMolecular epidemiologyOutbreakVREWhole genome sequencing

Identifiers

PMID29588851
PMCPMC5863837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.